Scientific notes

Organ-on-chip applications in drug discovery: an end-user perspective

Introduction

Organ-on-a-chip is regarded as a key new technology for research and drug development because it can predict how a potential medication will behave in human tissue structures – rather than standard animal models – long before it enters the clinic hence Organ-on-chip applications in drug discovery.

Organ-on-chip technologies are used to produce, in combination with grown live human cells, an experimental platform to recreate the physiologic and mechanical microenvironment of whole living organs.

3d-cell-culture-organ-on-chip-drug-development

The microphysiological systems (MPS) enable the investigation in an organ-specific context of complicated human physiology and disease. These in vitro models can revolutionize the discovery of drugs and their development through greater prediction by researchers of human reactions to pharmaceuticals, including safety and efficacy.

How to culture vascularized & immunocompetent 3D models in a standard Multiwell

Abstract of organ-on-chip applications in drug discovery: an end user perspective

The author states that “Organ-on-chip (OoC) systems are in vitro microfluidic models that mimic the microstructures, functions and physiochemical environments of whole living organs more accurately than two-dimensional models.

While still in their infancy, OoCs are expected to bring ground-breaking benefits to a myriad of applications, enabling more human-relevant candidate drug efficacy and toxicity studies, and providing greater insights into mechanisms of human disease. Here, we explore a selection of applications of OoC systems.

The future directions and scope of implementing OoCs across the drug discovery process are also discussed.”

References

Clapp N, Amour A, Rowan WC, Candarlioglu PL. Organ-on-chip applications in drug discovery: an end-user perspective. Biochem Soc Trans. 2021 Aug 16:BST20210840. DOI: 10.1042/BST20210840. Epub ahead of print. PMID: 34397080.

Related Posts

3d-cell-culture-Cherry-Biotech-CubiX-microphysiological-system-adipocytes-diabetes-adiponectin
Co-culture With Human Breast Adipocytes Differentially Regulates ...
Introduction In postmenopausal women, fat mass and adipose-tissue mass (see Human Breast Adipocytes) are closely linked to obesity and bre...
Read more
Tumor_targeting
3D cell culture and anticancer drug testing...
Efficacity and toxicity of candidate anticancer drugs on 3D cell culture model has been much lower than on 2D cell culture models over the p...
Read more
3d-cell-culture-Cherry-Biotech-CubiX-microphysiological-system-adipocytes-diabetes-adiponectin
Probing Insulin Sensitivity with Metabolically Competent Human St...
Introduction Adipose Tissue is very versatile and essential for studies related to Obesity and Diabetes, however, the high buoyancy, fra...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy